Role of extracellular vesicles secretion in paclitaxel resistance of prostate cancer cells

Abstract

Aim: The development of chemotherapy resistance is the major obstacle in the treatment of advanced prostate cancer (PCa). Extracellular vesicles (EVs) secretion plays a significant role among different mechanisms contributing to chemoresistance. Hence, inhibition of EVs release may increase the efficacy of chemotherapeutic drugs against PCa.

Methods: Paclitaxel (PTX) resistant PCa cells (PC3-R and DU145-R) were treated with GW4869, a known exosome biogenesis inhibitor. EVs were isolated from the conditioned media by ExoQuick-based precipitation method and characterized for concentration and size distribution by nanoparticle tracking analysis. The effect of GW4869 treatment on the survival and growth of PCa cells was assessed by MTT, and colony formation assays in vitro, and ectopic PC3-R xenografts in male athymic nude mice in vivo. The effect of other EV biogenesis inhibitors, imipramine and dimethyl amiloride (DMA), treatment was also analyzed on the survival of PC3-R cells.

Results: GW4869 (10-20 µM) treatment of PTX resistant PCa cells significantly reduced the release of small EVs (50-100 nm size range) while increasing the release of larger EVs (> 150 nm in size), and inhibited their clonogenicity. Moreover, GW4869 (5-20 µM) treatment (24-72h) significantly inhibited the survival of PC3-R cells in a dose-dependent manner. We observed a similar growth inhibition with both imipramine (5-20 µg/mL) and DMA (5-20 µg/mL) treatment in PC3-R cells. Furthermore, GW4869 treatment (IP) in mice bearing PC3-R xenografts significantly reduced the tumor weight (65% reduction, P = 0.017) compared to the vehicle-treated control mice without causing any noticeable toxicity.

Conclusion: Inhibiting the release of EVs could sensitize the resistant PCa cells to chemotherapy.

Keywords

Prostate cancer / extracellular vesicles / GW4869 / chemoresistance / paclitaxel

References

[1] Siegel RL,Fuchs HE.Cancer statistics, 2021.CA Cancer J Clin2021;71:7-33

[2] Trachtenberg J.Hormonal management of stage D carcinoma of the prostate.Urol Clin North Am1987;14:685-94.

[3] Huggins C.The treatment of cancer of the prostate : (the 1943 address in surgery before the royal college of physicians and surgeons of canada).Can Med Assoc J1944;50:301-7 PMCID:1581643

[4] Heidenreich A,Bellmunt J.European Association of UrologyEAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.Eur Urol2014;65:467-79

[5] Hotte SJ.Current management of castrate-resistant prostate cancer.Curr Oncol2010;17 Suppl 2:S72-9

[6] Smith DC.Paclitaxel in the treatment of hormone-refractory prostate cancer. Semin Oncol. 1999;26(1 Suppl 2):109-11.

[7] Tannock IF,Berry WR.TAX 327 InvestigatorsDocetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer.N Engl J Med2004;351:1502-12

[8] Petrylak DP,Hussain MH.Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer.N Engl J Med2004;351:1513-20

[9] Schiff PB,Horwitz SB.Promotion of microtubule assembly in vitro by taxol.Nature1979;277:665-7

[10] Wang X,Chen X.Drug resistance and combating drug resistance in cancer.Cancer Drug Resist2019;2:141-60

[11] Housman G,Heerboth S.Drug resistance in cancer: an overview.Cancers (Basel)2014;6:1769-92

[12] Gottesman MM,Bates SE.Multidrug resistance in cancer: role of ATP-dependent transporters.Nat Rev Cancer2002;2:48-58

[13] Heldin CH,Pietras K.High interstitial fluid pressure - an obstacle in cancer therapy.Nat Rev Cancer2004;4:806-13

[14] Kyle AH,Yeoman DM.Limited tissue penetration of taxanes: a mechanism for resistance in solid tumors.Clin Cancer Res2007;13:2804-10

[15] Trédan O,Patel K.Drug resistance and the solid tumor microenvironment.J Natl Cancer Inst2007;99:1441-54

[16] Carceles-Cordon M,Gomella L,Rodriguez-Bravo V.Cellular rewiring in lethal prostate cancer: the architect of drug resistance.Nat Rev Urol2020;17:292-307 PMCID:PMC7218925

[17] Li Y,Mooney SM.Resistance to paclitaxel increases the sensitivity to other microenvironmental stresses in prostate cancer cells.J Cell Biochem2011;112:2125-37

[18] Shedden K,Chandaroy P,Rosania GR.Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles.Cancer Res2003;63:4331-7.

[19] Bebawy M,Lee E.Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells.Leukemia2009;23:1643-9

[20] Sousa D,Vasconcelos MH.Intercellular transfer of cancer drug resistance traits by extracellular vesicles.Trends Mol Med2015;21:595-608

[21] Namee NM.Extracellular vesicles and anti-cancer drug resistance.Biochimica et Biophysica Acta (BBA) - Reviews on Cancer2018;1870:123-36

[22] Sedgwick AE.The biology of extracellular microvesicles.Traffic2018;19:319-27 PMCID:PMC6922305

[23] Maacha S,Jimenez L.Extracellular vesicles-mediated intercellular communication: roles in the tumor microenvironment and anti-cancer drug resistance.Mol Cancer2019;18:55

[24] Panigrahi GK.Exosomes-based biomarker discovery for diagnosis and prognosis of prostate cancer.Front Biosci (Landmark Ed)2017;22:1682-96

[25] Mathieu M,Lavieu G.Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication.Nat Cell Biol2019;21:9-17

[26] Dong X,Ni J.Exosomes and breast cancer drug resistance.Cell Death Dis2020;11: PMCID:PMC7673022

[27] Catalano M.Inhibiting extracellular vesicles formation and release: a review of EV inhibitors.J Extracell Vesicles2020;9:1703244 PMCID:PMC6968539

[28] Trajkovic K,Chiantia S.Ceramide triggers budding of exosome vesicles into multivesicular endosomes.Science2008;319:1244-7

[29] Shamseddine AA,Hannun YA.Roles and regulation of neutral sphingomyelinase-2 in cellular and pathological processes.Adv Biol Regul2015;57:24-41

[30] Savina A,Vidal M.Exosome release is regulated by a calcium-dependent mechanism in K562 cells.J Biol Chem2003;278:20083-90

[31] Panigrahi GK,Peak TC.Hypoxia-induced exosome secretion promotes survival of African-American and Caucasian prostate cancer cells.Sci Rep2018;8:3853 PMCID:PMC5832762

[32] Peak TC,Praharaj PP.Syntaxin 6-mediated exosome secretion regulates enzalutamide resistance in prostate cancer.Mol Carcinog2020;59:62-72 PMCID:PMC6916724

[33] Hu Y,Mu L.Fibroblast-derived exosomes contribute to chemoresistance through priming cancer stem cells in colorectal cancer.PLoS One2015;10:e0125625

[34] Richards KE,Fishel ML,Littlepage LE.Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells.Oncogene2017;36:1770-8

[35] Souchek JJ,Hill TK.Combination treatment with orlistat-containing nanoparticles and taxanes is synergistic and enhances microtubule stability in taxane-resistant prostate cancer cells.Mol Cancer Ther2017;16:1819-30 PMCID:PMC5598554

[36] Takeda M,Mamiya K.The establishment of two paclitaxel-resistant prostate cancer cell lines and the mechanisms of paclitaxel resistance with two cell lines.Prostate2007;67:955-67

[37] Ramteke A,Agarwal C.Exosomes secreted under hypoxia enhance invasiveness and stemness of prostate cancer cells by targeting adherens junction molecules.Mol Carcinog2015;54:554-65

[38] Kumar A,Su Y.Brain cell-derived exosomes in plasma serve as neurodegeneration biomarkers in male cynomolgus monkeys self-administrating oxycodone.EBioMedicine2021;63:103192

[39] Rios-Colon L,Kim S.Carnitine palmitoyltransferase 1 regulates prostate cancer growth under hypoxia.Cancers (Basel)2021;13:6302 PMCID:PMC8699124

[40] Patterson SA,Brinkley TE.Detection of the receptor for advanced glycation endproducts in neuronally-derived exosomes in plasma.Biochem Biophys Res Commun2018;500:892-6 PMCID:PMC6082160

[41] Brasseur K,Asselin E.Chemoresistance and targeted therapies in ovarian and endometrial cancers.Oncotarget2017;8:4008-42

[42] Lu C.Chemoresistance in gliomas.Mol Cell Biochem2008;312:71-80

[43] Lohiya V,Sonpavde G.Role of chemotherapy and mechanisms of resistance to chemotherapy in metastatic castration-resistant prostate cancer.Clin Med Insights Oncol2016;10:57-66

[44] Fontana F,Melling GE.Extracellular vesicles: emerging modulators of cancer drug resistance.Cancers (Basel)2021;13:749

[45] Kumar A.Exosomes in hypoxia-induced remodeling of the tumor microenvironment.Cancer Lett2020;488:1-8

[46] Kumar A.Hypoxia in tumor microenvironment regulates exosome biogenesis: molecular mechanisms and translational opportunities.Cancer Lett2020;479:23-30

[47] Menck K,Worst TS.Neutral sphingomyelinases control extracellular vesicles budding from the plasma membrane.Journal of Extracellular Vesicles2017;6:1378056

[48] Bianco F,Novellino L.Acid sphingomyelinase activity triggers microparticle release from glial cells.EMBO J2009;28:1043-54

[49] Kulshreshtha A,Agrawal A.Proinflammatory role of epithelial cell-derived exosomes in allergic airway inflammation.J Allergy Clin Immunol2013;131:1194-203, 1203.e1

[50] Chairoungdua A,Pochard P,Caplan MJ.Exosome release of β-catenin: a novel mechanism that antagonizes Wnt signaling.J Cell Biol2010;190:1079-91 PMCID:PMC3101591

[51] Dinkins MB,Wang G,Bieberich E.Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer’s disease.Neurobiol Aging2014;35:1792-800

[52] Chalmin F,Mignot G.Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells.J Clin Invest2010;120:457-71

[53] Matsumoto A,Nishikawa M.Accelerated growth of B16BL6 tumor in mice through efficient uptake of their own exosomes by B16BL6 cells.Cancer Sci2017;108:1803-10 PMCID:PMC5581513

[54] Corcoran C,O'Brien K.Docetaxel-resistance in prostate cancer: evaluating associated phenotypic changes and potential for resistance transfer via exosomes.PLoS One2012;7:e50999

[55] Wang S,Xu M.Exosomes secreted by mesenchymal stromal/stem cell-derived adipocytes promote breast cancer cell growth via activation of Hippo signaling pathway.Stem Cell Res Ther2019;10:117 PMCID:PMC6458638

[56] Nakazawa Y,Koizumi H,Nakahashi-Oda C.Tumor-derived extracellular vesicles regulate tumor-infiltrating regulatory T cells via the inhibitory immunoreceptor CD300a.Elife2021;10:e61999

[57] Wu X,Wei Y,Wood DK.Extracellular vesicles mediate the intercellular exchange of nanoparticles.Adv Sci (Weinh)2022;9:e2102441 PMCID:PMC8895114

[58] Gon Y,Inoue T.Selective release of miRNAs via extracellular vesicles is associated with house-dust mite allergen-induced airway inflammation.Clin Exp Allergy2017;47:1586-98

[59] Essandoh K,Wang X.Blockade of exosome generation with GW4869 dampens the sepsis-induced inflammation and cardiac dysfunction.Biochim Biophys Acta2015;1852:2362-71 PMCID:PMC4581992

[60] Vuckovic S,Rickards DA.The cationic small molecule GW4869 is cytotoxic to high phosphatidylserine-expressing myeloma cells.Br J Haematol2017;177:423-40